{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:55:04Z","timestamp":1785884104085,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007761","name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006691","name":"Sher-e-Bangla Agricultural University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","award":["EC019-19_FJD"],"award-info":[{"award-number":["EC019-19_FJD"]}],"id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ard.2026.03.025","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:41:15Z","timestamp":1776915675000},"page":"1255-1267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-0096","authenticated-orcid":false,"given":"Esperanza","family":"Naredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Olivas-Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Recuero-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Martins-Martinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Tenazinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Margarida","family":"Duarte-Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Guill\u00e9n-Astete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodr\u00edguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Blanco-C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina L.","family":"Boteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mera-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"P\u00e9rez-Pamp\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda L\u00f3pez","family":"Gol\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Campos Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Juan","family":"Frag\u00edo G\u00edl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Gonz\u00e1lez Mazario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vergara-Dangond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Beatriz","family":"Paredes-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Simona","family":"Stoenoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien Nzeusseu","family":"Toukap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Durnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"de Agust\u00edn de Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A.","family":"A\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Coronel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther F.","family":"Vicente-Rabaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Padovano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Gouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Leboime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Breban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Uson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Villaverde-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Roberto","family":"Migu\u00e9lez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"P\u00e9rez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Meraz-Ostiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Polino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Finzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Kanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Jandova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00e1nzazu","family":"Mediero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Herencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Herrero-Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Largo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ard.2026.03.025_bib0001","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ard.2026.03.025_bib0002","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ard.2026.03.025_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1759720X16687481","article-title":"Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential","volume":"9","author":"Kuriya","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.ard.2026.03.025_bib0004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/annrheumdis-2014-206478","article-title":"Safety and efficacy of baricitinib at 24\u2005weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate","volume":"74","author":"Keystone","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.ard.2026.03.025_bib0005","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","article-title":"Baricitinib in patients with refractory rheumatoid arthritis","volume":"374","author":"Genovese","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","article-title":"Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000410","article-title":"Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis","volume":"3","author":"Emery","year":"2017","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.ard.2026.03.025_bib0008","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/art.39953","article-title":"Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment","volume":"69","author":"Fleischmann","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2026.03.025_bib0009","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ard.2026.03.025_bib0010","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1093\/rheumatology\/keaa858","article-title":"Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway","volume":"60","author":"Fitton","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ard.2026.03.025_bib0011","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/rheumatology\/keac068","article-title":"Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data","volume":"61","author":"Barbulescu","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2026.03.025_bib0012","doi-asserted-by":"crossref","first-page":"868","DOI":"10.55563\/clinexprheumatol\/pudtpo","article-title":"Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study","volume":"39","author":"Guidelli","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2026.03.025_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004291","article-title":"PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs","volume":"10","author":"van de Laar","year":"2024","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.ard.2026.03.025_bib0014","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2012-202669","article-title":"Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study","volume":"73","author":"Andersen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-015-0567-8","article-title":"Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early rheumatoid arthritis: an observational study","volume":"17","author":"Kelly","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000616","article-title":"Knee joint synovitis: study of correlations and diagnostic performances of ultrasonography compared with histopathology","volume":"4","author":"Najm","year":"2018","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.ard.2026.03.025_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000951","article-title":"Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score","volume":"5","author":"Just","year":"2019","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0018","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.22461","article-title":"Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression","volume":"57","author":"Naredo","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ard.2026.03.025_bib0019","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2005.044628","article-title":"Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab","volume":"65","author":"Filippucci","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.03.025_bib0020","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.23682","article-title":"Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis","volume":"58","author":"Naredo","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2026.03.025_bib0021","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10067-007-0738-3","article-title":"Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography","volume":"27","author":"Iagnocco","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.03.025_bib0022","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/annrheumdis-2015-207709","article-title":"Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study","volume":"75","author":"D'Agostino","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13075-019-1930-y","article-title":"Assessing synovitis in the hands in patients with rheumatoid arthritis by ultrasound: an agreement study exploring the most inflammatory active side from two Norwegian trials","volume":"21","author":"Terslev","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ard.2026.03.025_bib0024","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/03009742.2020.1845394","article-title":"Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis","volume":"50","author":"Hammer","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ard.2026.03.025_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41927-020-00153-4","article-title":"Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritis","volume":"4","author":"Razmjou","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.ard.2026.03.025_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211014019","article-title":"Baricitinib in the treatment of rheumatoid arthritis: clinical and ultrasound evaluation of a real-life single-centre experience","volume":"13","author":"Tesei","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"30","key":"10.1016\/j.ard.2026.03.025_bib0027","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026739","article-title":"The beneficial effect of baricitinib on ultrasound-detected synovial inflammation and bone damage in rheumatoid arthritis: preliminarily data from single center-based observational study for 24 weeks","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ard.2026.03.025_bib0028","article-title":"Ultrasound response to tofacitinib in patients with rheumatoid arthritis: data from a multicenter 24 weeks prospective study","volume":"9","author":"German\u00f2","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.ard.2026.03.025_bib0029","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s40744-024-00712-y","article-title":"Clinical and ultrasonographic remission in bio-na\u00efve and bio-failure patients with rheumatoid arthritis at 24 weeks of upadacitinib treatment: the UPARAREMUS real-life study","volume":"11","author":"Picchianti Diamanti","year":"2024","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.ard.2026.03.025_bib0030","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/biomedicines13061339","article-title":"Ultrasound evaluation of therapeutic response to tofacitinib and upadacitinib in patients with rheumatoid arthritis-real-life clinical data","volume":"13","author":"Boyadzhieva","year":"2025","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.ard.2026.03.025_bib0031","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.33312","article-title":"Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity","volume":"64","author":"Foltz","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ard.2026.03.025_bib0033","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/ket405","article-title":"Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion","volume":"53","author":"Kawashiri","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ard.2026.03.025_bib0034","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/annrheumdis-2018-213217","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13075-020-02340-7","article-title":"The Janus kinase 1\/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis","volume":"22","author":"Thudium","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ard.2026.03.025_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037447","article-title":"Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy","volume":"7","author":"Niki","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ard.2026.03.025_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.ard.2026.03.025_bib0038","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"Suppl 2","key":"10.1016\/j.ard.2026.03.025_bib0039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/35.suppl_2.4","article-title":"Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers","volume":"35","author":"van Riel","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2026.03.025_bib0040","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/annrheumdis-2013-204920","article-title":"How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?","volume":"74","author":"Fleischmann","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2026.03.025_bib0041","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3899\/jrheum.181095","article-title":"OMERACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on","volume":"46","author":"Bruyn","year":"2019","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0042","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system","volume":"3","author":"D'Agostino","year":"2017","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ard.2026.03.025_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000427","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system","volume":"3","author":"Terslev","year":"2017","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.ard.2026.03.025_bib0044","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/annrheumdis-2017-211585","article-title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology","volume":"76","author":"M\u00f6ller","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ard.2026.03.025_bib0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2020-219816","article-title":"EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)","volume":"80","author":"Costantino","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2026.03.025_bib0046","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.berh.2019.01.006","article-title":"MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis","volume":"32","author":"Lerner","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ard.2026.03.025_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1387585","article-title":"Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomised controlled trials","volume":"15","author":"Cai","year":"2024","journal-title":"Front Pharmacol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:38:23Z","timestamp":1785883103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0003496726002128"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.03.025","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}